Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. Forge has developed a fundamentally new approach for the discovery of metalloprotein inhibitors by focusing first on the metal in the enzyme active site. Using bio-inorganic and medicinal chemistry principles, full-length inhibitors are developed using a novel fragment growth strategy incorporating computational and structural biology.
|HQ||San Diego, CA, US||Map|
|Employees (est.) (May 2017)||14|
Forge Therapeutics total Funding
Forge Therapeutics latest funding size
Time since last funding
|5 years ago|
Forge Therapeutics investors
|Tech Coast Angels, WS Investments, MP Healthcare Venture Management, Alexandria Venture, CARB-X, Evotec AG, MagnaSci Ventures|
Forge Therapeutics has 546 Twitter Followers. The number of followers has increased 0.5% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Forge Therapeutics founded?
Forge Therapeutics was founded in 2015.
Who are Forge Therapeutics key executives?
Forge Therapeutics's key executives are Brian Dorsey, Mario Polywka and John Schmid.
How many employees does Forge Therapeutics have?
Forge Therapeutics has 14 employees.
Who are Forge Therapeutics competitors?
Competitors of Forge Therapeutics include Selleck Chemicals, Mcneil and The Searle Company.
Where is Forge Therapeutics headquarters?
Forge Therapeutics headquarters is located at 10578 Science Center Dr #205, San Diego.
Where are Forge Therapeutics offices?
Forge Therapeutics has an office in San Diego.
How many offices does Forge Therapeutics have?
Forge Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies